Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9720669 | 1.00 | HTR2A (0.44) | HTR2ACSNK1ENAAAMEN1KMT2A | |
| SCHEMBL9720865 | 1.00 | HTR2A (0.44) | HTR2ACSNK1ENAAAMEN1KMT2A | |
| SCHEMBL4801716 | 1.00 | HTR2A (0.44) | HTR2ACSNK1ENAAAMEN1KMT2A | |
| SCHEMBL4803907 | 1.00 | HTR2A (0.44) | HTR2ACSNK1ENAAAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL4799254 | 0.98 | HTR2A (0.43) | HTR2ACSNK1ENAAAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL1170862 | 0.98 | HTR2A (0.43) | HTR2ACSNK1ENAAAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL4618491 | 0.98 | HTR2A (0.43) | HTR2ACSNK1ENAAAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL6122957 | 0.98 | HTR2A (0.43) | HTR2ACSNK1ENAAAMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL11785349 | 0.98 | HTR2A (0.43) | HTR2ACSNK1ENAAAMEN1KMT2A | |
| Bromide SCHEMBL10626002 | 0.98 | HTR2A (0.43) | HTR2ACSNK1ENAAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11043405-A | — | — | None | — | — | JP | disclosed |
| US-20200048508-A1 | SILICONE COMPOSITION FOR RELEASE PAPER OR RELEASE FILM | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
| EP-3524655-A1 | SILICONE COMPOSITION FOR RELEASE PAPER OR RELEASE FILM | Shin-Etsu Chemical Co., Ltd. (JP) | 2019-08-14 | — | — | EP | disclosed |
| US-10156566-B2 | Detoxification of microbial virulence factors in oral cavity | THE PROCTER & GAMBLE COMPANY (US) | 2018-12-18 | — | — | US | disclosed |
| EP-3292215-A1 | DETOXIFICATION OF MICROBIAL VIRULENCE FACTORS IN ORAL CAVITY | The Procter and Gamble Company (US) | 2018-03-14 | — | — | EP | disclosed |
| US-20170119643-A1 | DETOXIFICATION OF MICROBIAL VIRULENCE FACTORS IN ORAL CAVITY | THE PROCTER & GAMBLE COMPANY | 2017-05-04 | — | — | US | disclosed |
| WO-2016179561-A1 | DETOXIFICATION OF MICROBIAL VIRULENCE FACTORS IN ORAL CAVITY | THE PROCTER & GAMBLE COMPANY (US) | 2016-11-10 | — | — | WO | disclosed |
| US-20160158960-A1 | IRON-CORROSION INHIBITION METHOD, AND WOOD TREATMENT METHOD | KATAYAMA CHEMICAL INC. (JP) | 2016-06-09 | — | — | US | disclosed |
| US-7709550-B2 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJIFILM CORPORATION (JP) | 2010-05-04 | — | — | US | disclosed |
| EP-1762599-B1 | Ink composition, inkjet recording method, printed material, process for producing lithographic plate, and lithographic printing plate | FUJIFILM CORP (JP) | 2008-03-05 | — | — | EP | disclosed |
| EP-1762599-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic plate, and lithographic printing plate | FUJIFILM Corporation (JP) | 2007-03-14 | — | — | EP | disclosed |
| US-20070052790-A1 | Ink composition, inkjet recording method, printed material, process for producing lithographic printing plate, and lithographic printing plate | FUJI PHOTO FILM CO., LTD. | 2007-03-08 | — | — | US | disclosed |
| EP-1505058-A4 | METHOD FOR PRODUCING ALKYLDIMETHYLBENZYLAMMONIUM CHLORIDES | NEDD MARKETING SA (RU) | 2005-06-29 | — | — | EP | disclosed |
| WO-2003091197-A1 | METHOD FOR PRODUCING ALKYLDIMETHYLBENZYLAMMONIUM CHLORIDES | NEDD MARKETING SA (RU) | 2003-11-06 | — | — | WO | disclosed |
| JP-H1143405-A | ANTIMICROBIAL PROCESSING AGENT FOR FIBER HAVING LOW IRRITATION PROPERTY | SANYO CHEM IND LTD | 1999-02-16 | — | — | JP | disclosed |
| EP-0328466-B1 | EMULSIFIABLE CONCENTRATES OF BIOCIDAL MATERIALS, AQUEOUS MICROEMULSIONS OBTAINED AND USE OF THESE MICROEMULSIONS IN THE TREATMENT OF WOOD | XYLOCHIMIE (FR) | 1992-04-29 | — | — | EP | disclosed |
| US-5013748-A | Triazole, quaternary ammonium and benzimidazole fungicides | XYLOCHIMIE (FR) | 1991-05-07 | — | — | US | disclosed |
| EP-0328466-A1 | Emulsifiable concentrates of biocidal materials, aqueous microemulsions obtained and use of these microemulsions in the treatment of wood | XYLOCHIMIE (FR) | 1989-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170119643-A1 | DETOXIFICATION OF MICROBIAL VIRULENCE FACTORS IN ORAL CAVITY | GSTM2, GSTA2, GSTA1 | HTR2A 3556/4885CSNK1E 4693/4885NAAA 853/4885 |
| US-10156566-B2 | Detoxification of microbial virulence factors in oral cavity | GSTM2, GSTA2, GSTA1 | HTR2A 3556/4885CSNK1E 4693/4885NAAA 853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.